Clinical Trial Update: ZD 1839 in Treating Patients With Locally Advanced or Metastatic Colorectal Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial of ZD 1839 (gefitinib) in locally advanced or metastatic colorectal cancer completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Gefitinib (ZD 1839) (gefitinib)

Snippet

Sponsor: The University of Texas Health Science Center at San Antonio | Conditions: Colorectal Cancer | Phase 2 | Status: COMPLETED